Detalles de la búsqueda
1.
Bayesian survival extrapolation for cost-effectiveness analysis: a case study of RELAY for ramucirumab in combination with erlotinib in the treatment of non-small-cell lung cancer.
J Med Econ
; 26(1): 1479-1488, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38035666
2.
Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study.
Adv Ther
; 40(7): 3135-3168, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37221352
3.
Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea.
Drugs Real World Outcomes
; 10(1): 131-143, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36456850
4.
Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.
J Med Econ
; 18(11): 954-66, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26212479
Resultados
1 -
4
de 4
1
Próxima >
>>